Which is Better to Lower IOP – Travatan vs. Lumigan vs. Xalatan
October 21, 2010
A study compared Xalatan/Timolol combination to Travatan and Lumigan/Timoptic combinations. The Lumigan combination lowered the IOP the most (1.7 more than Xalatan, 0.7 more than Travatan). I dread getting an earful from the drug reps about this…
You might also enjoy...
- Which Is More Damaging to the Conjunctiva- Timoptic or Xalatan?
- Xalatan, Lumigan or Travatan for Glaucoma?
- Aton Pharma Acquires Marketing Rights to Preservative-Free Timolol Product Line from Merck
- New Lumigan Eye Drop Formulation for Glaucoma From Allergan Approved by FDA
- Lumigan vs. Travatan vs. Xalatan
Comments
Jump down to form below to submit your own comments
I am a drug rep, but I haven’t bothered wasting my breath talking about this study. It is flawed and does not represent how an ophthalmologist would treat glaucoma.
of course all studies are flawed, and each drug rep makes sure to point out the flaws of a study that makes his drug appear inferior. that’s his job- cant blame him!
but im not sure what you mean when you say this is not how an ophthalmologist treats glaucoma. are you suggesting we dont give combination drugs, and we dont care which one might be better?
yes doctor. lumigan really showed superior iop control over xalatan and travatan. even in the in clinic experience, doctors agree this.
thanks.
you always have to keep in mind about the best efficacious drug to delay or halt the progression of glaucoma. and of course there is not a single study which can prove the superiority of travatan or xalatan over lumigan. even now the hypermea and the skin hyper pigmentation also taken care by lumigan 0.01%